Efficacy of a single intravenous dose of amphotericin B for Candida urinary tract infections: further favorable experience.
about
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Biofilm formation by and antifungal susceptibility of Candida isolates from urine.Colonization and antifungals susceptibility patterns of Candida species isolated from hospitalized patients in ICUs and NICUs.Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.[Candiduria! What now? : Therapy of urinary tract infections with Candida].Candida urinary tract infections--treatment.
P2860
Efficacy of a single intravenous dose of amphotericin B for Candida urinary tract infections: further favorable experience.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Efficacy of a single intraveno ...... further favorable experience.
@en
Efficacy of a single intraveno ...... further favorable experience.
@nl
type
label
Efficacy of a single intraveno ...... further favorable experience.
@en
Efficacy of a single intraveno ...... further favorable experience.
@nl
prefLabel
Efficacy of a single intraveno ...... further favorable experience.
@en
Efficacy of a single intraveno ...... further favorable experience.
@nl
P2093
P1476
Efficacy of a single intraveno ...... further favorable experience.
@en
P2093
Espinel-Ingroff A
Stanfield J
P304
P356
10.1046/J.1469-0691.2003.00711.X
P577
2003-10-01T00:00:00Z